* Pro-Dex Inc PDEX.OQ reported a quarterly adjusted loss
of 17
cents per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of 29
cents. The lone analyst forecast for the quarter was
for earnings of 32 cents per share.
* Revenue rose 7.7% to $11.94 million from a year ago;
analysts
expected $11.20 million.
* Pro-Dex Inc's reported EPS for the quarter was a loss
of 17
cents.
* The company reported a quarterly loss of $615 thousand.
* Pro-Dex Inc shares had risen by 18.7% this quarter and
gained 17.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Pro-Dex Inc is
$27.00
This summary was machine generated from LSEG data November 3 at
04:16 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.32 -0.17 Missed
Jun. 30 2023 0.33 0.42 Beat
Mar. 31 2023 0.26 0.36 Beat
Dec. 31 2022 0.29 0.24 Missed